Protective efficacy of antigenic fractions in mouse models of cryptococcosis

MK Mansour, LE Yauch, JB Rottman… - Infection and …, 2004 - Am Soc Microbiol
Infections due to the encapsulated fungus Cryptococcus neoformans are a significant cause
of morbidity and mortality in patients with impaired T-cell function, particularly those with …

High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library

DO Beenhouwer, RJ May, P Valadon… - The Journal of …, 2002 - journals.aai.org
Cryptococcus neoformans causes a life-threatening meningoencephalitis in a significant
percentage of AIDS patients. Mice immunized with a glycoconjugate vaccine composed of …

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity

SJ Devi, R Schneerson, W Egan, TJ Ulrich… - Infection and …, 1991 - Am Soc Microbiol
We synthesized Cryptococcus neoformans serotype A glucuronoxylomannan (GXM)
conjugate vaccines under conditions suitable for human use to prevent disseminated …

A call to arms: quest for a cryptococcal vaccine

MCC Van Dyke, FL Wormley - Trends in microbiology, 2018 - cell.com
Cryptococcosis remains a significant cause of morbidity and mortality world-wide,
particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically …

Divalent Cp15–23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection

K Liu, D Zai, D Zhang, Q Wei, G Han, H Gao… - Parasite …, 2010 - Wiley Online Library
Cryptosporidiosis, caused by Cryptosporidium parvum, is life‐threatening in individuals with
compromised immune systems and a common serious primary cause of outbreaks of …

[HTML][HTML] Glucosylceramide administration as a vaccination strategy in mouse models of cryptococcosis

V Mor, AM Farnoud, A Singh, A Rella, H Tanno, K Ishii… - PloS one, 2016 - journals.plos.org
Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of
the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in …

A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection

R Fleuridor, A Lees, L Pirofski - The Journal of Immunology, 2001 - journals.aai.org
Abstract Defined Abs to the Cryptococcus neoformans capsular polysaccharide
glucuronoxylomannan (GXM) have been shown to be protective against experimental …

A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis

R Fleuridor, Z Zhong, L Pirofski - The Journal of infectious …, 1998 - academic.oup.com
Antifungal therapy cannot eradicate Cryptococcus neoformans infections in
immunosuppressed patient groups. Therefore, adjunctive antibody-based therapy is being …

Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans

CJ Crawford, L Liporagi-Lopes, C Coelho… - ACS Infectious …, 2024 - ACS Publications
Cryptococcus neoformans is a fungus classified by the World Health Organization as a
critically important pathogen, which poses a significant threat to immunocompromised …

[HTML][HTML] Titan Cells and Yeast Forms of Cryptococcus neoformans and Cryptococcus gattii Are Recognized by GXMR-CAR

MH Dos Santos, MP Machado, PR Kumaresan… - Microorganisms, 2021 - mdpi.com
Cryptococcosis, a systemic mycosis that affects both the immunocompromised and
immunocompetent, is caused by the inhalation of dehydrated yeasts or fungal spores of …